Medchemexpress LLC Dcc-3116 | 2543673-19-2 | 99.7% | 535.60 | 250 MG

Supplier:  Medchemexpress LLC 250MGHY160699

DCC-3116 is an orally active ULK1/2 inhibitor. It inhibits autophagy in lung cancer cells by targeting KRASG12C signaling, thereby reducing the proliferation of lung cancer cells and exhibiting anti-cancer effects.

• Orally active ULK1/2 inhibitor
• Inhibits autophagy in lung cancer cells
• Targets KRASG12C signaling to reduce cell proliferation
• Demonstrates anti-cancer effects
• High purity of 99.7%
• Consistent with chemical structure by ¹H NMR and MS
• Stable for 3 years at -20°C in pure form

Catalog No. 50-003-94811